Patent Applications published on Nov 16, 2023 - page 3

#601
US20230363903A1
Human necessities

MECHANICALLY EXPANDABLE HEART VALVES WITH SEVERAL TYPES OF INTERCONNECTED STRUTS

#602
US20230363904A1
Human necessities

TRANSCATHETER VALVE - SINGLE STENT STRUCTURE WITH FABRIC

#603
US20230363905A1
Human necessities

METHODS TO FOLD AND FORM DELIVERY SYSTEM BALLOONS TO REDUCE THE DEPLOYED THV HEIGHT ASYMMETRY

#604
US20230363906A1
Human necessities

DUAL-FLANGE PROSTHETIC VALVE FRAME

#605
US20230363907A1
Human necessities

PROSTHETIC CARDIAC VALVE SENSOR DEVICES, SYSTEMS, AND METHODS WITH IMAGING

#606
US20230363908A1
Human necessities

SUTURE ANCHOR FOR MINIMALLY INVASIVE HEART VALVE REPAIR

#607 ✅ Patent 12,213,883 granted on 2025-02-04
US20230363909A1
Human necessities

Method and apparatus for transvascular implantation of neo chordae tendinae

#608
US20230363910A1
Human necessities

DEVICE AND METHOD FOR TREATING VASCULAR INSUFFICIENCY

#609
US20230363911A1
Human necessities

HEART VALVE SEALING DEVICES AND DELIVERY DEVICES THEREFOR

#610
US20230363912A1
Human necessities

INTERCOMMISSURAL LEAFLET SUPPORT

#611
US20230363913A1
Human necessities

FASTENERS FOR PERCUTANEOUS DEVICES

#612
US20230363914A1
Human necessities

TRANSCATHETER VEIN FRAME FOR VENOUS INSUFFICIENCY

#613
US20230363915A1
Human necessities

ORTHOPAEDIC IMPLANT SYSTEMS INCLUDING INTERNAL NETWORKS AND METHODS OF REPAIR

#614
US20230363916A1
Human necessities

THREE-DIMENSIONAL SHAPED OBJECT, METHOD FOR MANUFACTURING SAME, AND CONTROL PROGRAM

#615
US20230363917A1
Human necessities

IMPLANT AND A METHOD OF MAKING THE IMPLANT AND A METHOD OF CALCULATING POROSITY OF A POROUS MATERIAL

#616 ✅ Patent 12,042,390 granted on 2024-07-23
US20230363918A1
Human necessities

Acetabular prosthesis with adjustable acetabular cup cages

#617
US20230363919A1
Human necessities

METHOD FOR PRODUCING A SLIDING SURFACE ELEMENT, SLIDING SURFACE ELEMENT AND KNEE JOINT ENDOPROSTHESIS

#618
US20230363920A1
Human necessities

UNIVERSAL TIBIAL INSERT WITH ENHANCED MEDIAL CONGRUENCE

#619
US20230363921A1
Human necessities

Shoulder Trial with Flexure

#620
US20230363922A1
Human necessities

METHODS AND DEVICES FOR ALTERING SPINAL LORDOSIS AND/OR KYPHOSIS

#621
US20230363923A1
Human necessities

REVERSIBLY, PROXIMALLY, AND DISTALLY EXPANDABLE SPINAL CAGE

#622
US20230363924A1
Human necessities

LORDOTIC EXPANDABLE FUSION IMPLANT

#623 ✅ Patent 12,109,124 granted on 2024-10-08
US20230363925A1
Human necessities

Intervertebral spacer that dynamically promotes bone growth

#624
US20230363926A1
Human necessities

DUAL-AXIS ADJUSTABLE SPINAL SYSTEMS AND INTERBODY FUSION DEVICES WITH FIXATION

#625
US20230363927A1
Human necessities

PREPACKAGED SACROILIAC JOINT IMPLANT WITH PREPACKED BONE GROWTH FACTOR

#626
US20230363928A1
Human necessities

INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT LUMBAR

#627
US20230363929A1
Human necessities

Implantable Joint Prosthesis with Integrated Biasing Systems

#628
US20230363930A1
Human necessities

METHOD FOR CONFIGURING A CONTROLLER AND ORTHOPEDIC DEVICE, AND COMPUTER PROGRAM PRODUCT

#629
US20230363931A1
Human necessities

METHOD FOR CONTROLLING AN ARTIFICIAL ORTHOTIC OR PROSTHETIC KNEE JOINT

#630
US20230363932A1
Human necessities

DISTAL LIMB PERFUSION CANNULA STENT & STENT CANNULA COVER

#631
US20230363933A1
Human necessities

WRIST BRACE

#632
US20230363934A1
Human necessities

MEDICAL DEVICE FOR RELAXING SPINE

#633
US20230363935A1
Human necessities

SPLINT DEVICE AND SPLINT SYSTEM COMPRISING SAME

#634 ✅ Patent 12,213,905 granted on 2025-02-04
US20230363936A1
Human necessities

Surgical platform system

#635 ✅ Patent 12,370,074 granted on 2025-07-29
US20230363937A1
Human necessities

OSTOMY PRODUCT WITH ANTI-REFLUX DEVICE

#636
US20230363938A1
Human necessities

POLYMERIC MANDIBULAR ADVANCEMENT DEVICES AND METHODS FOR MAKING AND USING THEM

#637
US20230363939A1
Human necessities

PATIENT CARE SYSTEMS WITH DYNAMIC GATEWAYS

#638
US20230363940A1
Human necessities

MEDICAL ICE SLURRY PRODUCTION AND DELIVERY SYSTEMS AND METHODS

#639
US20230363941A1
Human necessities

APPARATUS AND METHODS OF RETINAL INJECTION

#640
US20230363942A1
Human necessities

SURGICAL RING DESIGN WITH VARYING WALL THICKNESS AND CONSISTENT CROSS-SECTIONAL AREA

#641
US20230363943A1
Human necessities

Surgical Instruments For A Trabeculotomy Procedure

#642
US20230363944A1
Human necessities

ADJUSTABLE LASER PULSE CONTROL

#643
US20230363945A1
Human necessities

LASER PULSE CONTROL WITH SUB-CARRIER MODULATION

#644 ✅ Patent 12,257,189 granted on 2025-03-25
US20230363947A1
Human necessities

Personalization of excimer laser fibers

#645
US20230363948A1
Human necessities

PATIENT INTERFACE DEVICE FOR OPHTHALMIC SURGICAL LASER SYSTEM EMPLOYING A CAP FOR LENS CONE HANDLING

#646
US20230363949A1
Human necessities

PATIENT INTERFACE DEVICE FOR OPHTHALMIC SURGICAL LASER SYSTEM EMPLOYING A CAP FOR LENS CONE HANDLING

#647
US20230363950A1
Human necessities

BILATERAL COMPRESSION DEVICE

#648
US20230363951A1
Human necessities

GOGGLE ASSEMBLY

#649 ✅ Patent 11,986,375 granted on 2024-05-21
US20230363952A1
Human necessities

Inflatable earplug system

#650
US20230363953A1
Human necessities

DRESSINGS FOR REDUCED TISSUE INGROWTH

#651
US20230363954A1
Human necessities

METHOD FOR MAKING AN ABSORBENT ARTICLE AND ABSORBENT ARTICLE

#652
US20230363955A1
Human necessities

Dissector/Absorber Device for Surgical Applications

#653
US20230363956A1
Human necessities

MOISTURE DETECTION SYSTEM, METHOD FOR USE OF SYSTEM, AND LAMINATE FOR SYSTEM

#654
US20230363957A1
Human necessities

SANITARY ARTICLE WITH SHAPING ELEMENT

#655
US20230363958A1
Human necessities

ABSORBENT ARTICLE WITH DUAL CORE

#656
US20230363959A1
Human necessities

ABSORBENT ARTICLE

#657
US20230363960A1
Human necessities

TRANSPORT DEVICE

#658 ✅ Patent 11,951,051 granted on 2024-04-09
US20230363961A1
Human necessities

Lifting system and vehicle including a lifting system

#659
US20230363962A1
Human necessities

AUTOMATED PATIENT TURNER SYSTEM

#660
US20230363963A1
Human necessities

BED HAVING SNORE CONTROL BASED ON PARTNER RESPONSE

#661
US20230363964A1
Human necessities

PET BED WITH VITAL SIGN MONITORING

#662
US20230363965A1
Human necessities

SUPPORT ASSEMBLY ATTACHABLE TO A PATIENT SUPPORT AND PATIENT SUPPORT HAVING SAME

#663
US20230363966A1
Human necessities

DUAL-STRAP HOISTING DEVICE AND PATIENT LIFT APPARATUS COMPRISING THE SAME

#664 ✅ Patent 12,059,379 granted on 2024-08-13
US20230363967A1
Human necessities

Premature infant care system

#665
US20230363968A1
Human necessities

SURGICAL TABLE INCLUDING CABLE TAKE-UP MECHANISM

#666 ✅ Patent 12,150,902 granted on 2024-11-26
US20230363969A1
Human necessities

Surgical table

#667
US20230363970A1
Human necessities

SPINE PIANO

#668 ✅ Patent 11,992,449 granted on 2024-05-28
US20230363971A1
Human necessities

Hand motion detection device and control method, rehabilitation device and autonomous control system

#669
US20230363972A1
Human necessities

SLIDING DEVICE AND MOTION ASSISTING DEVICE INCLUDING THE SAME

#670
US20230363973A1
Human necessities

SYSTEM FOR ASSISTING MOBILITY-IMPAIRED INDIVIDUAL AND METHODS OF USE

#671
US20230363974A1
Human necessities

Mobility Aid

#672
US20230363975A1
Human necessities

TRAINING APPARATUS

#673 ✅ Patent 12,213,937 granted on 2025-02-04
US20230363976A1
Human necessities

Active compression decompression cardiopulmonary resuscitation chest compression feedback

#674
US20230363977A1
Human necessities

THERAPEUTIC EYE TREATMENT WITH GASES

#675
US20230363978A1
Human necessities

OFFSHORE PLATORM SLOT RECOVERY TOOL SYSTEM

#676
US20230363979A1
Human necessities

MEDICINE DISPENSER APPARATUS

#677
US20230363980A1
Human necessities

ADJUSTABLE BOTTLE HOLDER AND USE THEREOF

#678 ✅ Patent 11,992,464 granted on 2024-05-28
US20230363981A1
Human necessities

Enteral feeding pump systems, valve assemblies therefor and fluid flow control methods for same

#679
US20230363982A1
Human necessities

DENTAL COATING COMPOSITION

#680
US20230363983A1
Human necessities

DENTAL CERAMIC COLORING SOLUTION

#681
US20230363984A1
Human necessities

DENTAL COMPOSITION

#682
US20230363985A1
Human necessities

MEDICAL DEVICE SOLUTIONS FOR TREATING DENTAL DISEASE AND METHODS FOR THE TREATMENT OF DENTAL DISEASE

#683
US20230363986A1
Human necessities

EMULSIFIED COMPOSITION FOR SKIN

#684
US20230363987A1
Human necessities

Oral Care Compositions

#685
US20230363988A1
Human necessities

COMPOSITIONS FOR IMPROVED SKIN APPEARANCE AND METHODS OF USE THEREOF

#686 ✅ Patent 12,257,329 granted on 2025-03-25
US20230363989A1
Human necessities

Composition for the control of oral malodor compounds

#687 ✅ Patent 12,083,200 granted on 2024-09-10
US20230363990A1
Human necessities

Zinc oxide particles, photostable UV filters, and methods of use thereof

#688
US20230363991A1
Human necessities

Oral Care Compositions

#689
US20230363992A1
Human necessities

SILICONE-FREE ANTIPERSPIRANT AND DEODORANT COMPOSITIONS

#690
US20230363993A1
Human necessities

TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AT A CONTENT RANGING FROM 5% TO 30% BY WEIGHT AND AN OILY PHASE COMPRISING NON-SILICONE OILS

#691
US20230363994A1
Human necessities

DYEING COMPOSITION COMPRISING AN ANTHRAQUINONE CATIONIC DIRECT DYE, A POLYOL, AN ANIONIC SURFACTANT AND A NONIONIC POLYSACCHARIDE

#692
US20230363995A1
Human necessities

HAIR CLEANSING COMPOSITION

#693
US20230363996A1
Human necessities

HAIR CARE COMPOSITION

#694
US20230363997A1
Human necessities

COMPOSITION FOR SUPPRESSING SKIN IRRITATION OR INHIBITING SEBUM SECRETION

#695
US20230363998A1
Human necessities

COMPOSITION FOR PROMOTING THE SKIN MICROBIOME

#696
US20230363999A1
Human necessities

COMPOSITION FOR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH COMPRISING GROWTH FACTOR

#697
US20230364000A1
Human necessities

COMPOSITIONS COMPRISING COMBINATIONS OF COLLAGEN OR ELASTIN POLYPEPTIDES WITH ACTIVE INGREDIENTS AND METHODS OF USING SAME

#698
US20230364001A1
Human necessities

TOOTH ANTI-STAINING COMPOSITION, KIT AND METHOD OF USING THE SAME

#699
US20230364002A1
Human necessities

CRYSTAL INFUSED FEMININE HYGIENE WASHES

#700
US20230364003A1
Human necessities

COMPOSITIONS, METHODS, AND KITS FOR CLEANSING AND MOISTURIZING

#701
US20230364004A1
Human necessities

STABLE COMPOSITIONS CONTAINING A CANNABINOID

#702
US20230364005A1
Human necessities

Sunscreen Compositions and Methods of Use

#703 ✅ Patent 12,357,560 granted on 2025-07-15
US20230364006A1
Human necessities

COMPOSITION FOR TREATING OR PREVENTING SKIN PIGMENTATION

#704
US20230364007A1
Human necessities

ADMINISTRATION OF A PSYCHEDELIC COMPOUND

#705 ✅ Patent 12,115,244 granted on 2024-10-15
US20230364008A1
Human necessities

-acetylcysteine compositions and methods

#706
US20230364009A1
Human necessities

Implantable Medical Device for the Delivery of an Antipsychotic

#707
US20230364010A1
Human necessities

INTRANASAL DELIVERY OF OLANZAPINE BY PRECISION OLFACTORY DEVICE

#708 ✅ Patent 12,097,283 granted on 2024-09-24
US20230364011A1
Human necessities

Method for alleviating dry eye syndrome

#709
US20230364012A1
Human necessities

STABLE OPHTHALMIC COMPOSITION OF LOTEPREDNOL

#710
US20230364013A1
Human necessities

STABLE ORAL DISPERSIBLE FORMULATION FOR EPINEPHRINE

#711
US20230364014A1
Human necessities

SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND METHODS OF MAKING THEREOF

#712
US20230364015A1
Human necessities

PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES

#713
US20230364016A1
Human necessities

INTRACRANIAL DRUG DELIVERY MATERIALS AND METHODS

#714
US20230364017A1
Human necessities

BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION

#715
US20230364018A1
Human necessities

SYSTEMS FOR VACUUM MEDIATED LIPOSOME PREPARATION, AND METHODS FOR USING THE SAME

#716
US20230364019A1
Human necessities

Multi-targeting cell-derived nanoparticles as a versatile theranostic

#717
US20230364020A1
Human necessities

HYDROXYPROPYL METHYL CELLULOSE DERIVATIVES TO STABILIZE POLYPEPTIDES

#718
US20230364021A1
Human necessities

Sorafenib particles and uses thereof

#719 ✅ Patent 12,121,614 granted on 2024-10-22
US20230364022A1
Human necessities

Delayed release composition for peroral administration

#720
US20230364023A1
Human necessities

DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME

#721 ✅ Patent 12,144,895 granted on 2024-11-19
US20230364024A1
Human necessities

Stabilized formulations of lipid nanoparticles

#722
US20230364025A1
Human necessities

PROTEIN-RELEASE SYSTEM FOR SUSTAINED RELEASE OF PROTEINS

#723
US20230364026A1
Human necessities

STABILIZED SOLID NANOPARTICLE FORMULATIONS OF CANNABINOIDS AND CANNABINOID ANALOGS WITH REDUCED OSTWALD RIPENING FOR ORAL, INHALATION, NASAL AND PARENTERAL DRUG DELIVERY

#724
US20230364027A1
Human necessities

Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection

#725 ✅ Patent 12,213,951 granted on 2025-02-04
US20230364028A1
Human necessities

Treatment of autism with cannabidiol

#726
US20230364029A1
Human necessities

POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE

#727
US20230364030A1
Human necessities

PARENTERAL TREATMENTS INVOLVING AMINOADAMANTANE DERIVATIVES

#728
US20230364031A1
Human necessities

TREATMENT OF BRAIN COPPER DISORDERS

#729
US20230364032A1
Human necessities

USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS

#730
US20230364033A1
Human necessities

COMPOUNDS FOR TREATING VIRUS INFECTIONS

#731
US20230364034A1
Human necessities

METHODS OF INHIBITING DISEASES CAUSED BY RESPIRATORY VIRUSES

#732 ✅ Patent 12,280,023 granted on 2025-04-22
US20230364035A1
Human necessities

Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia

#733 ✅ Patent 12,150,921 granted on 2024-11-26
US20230364036A1
Human necessities

Epinephrine spray formulations

#734
US20230364037A1
Human necessities

CANCER THERAPEUTIC

#735
US20230364038A1
Human necessities

ANTI-INFECTIVE DOSAGE FORMS FOR PRODUCING A NASAL RINSE

#736
US20230364039A1
Human necessities

Methods of Managing Side Effects of a Vasopressin Receptor Antagonist Therapy

#737
US20230364040A1
Human necessities

EARLY ADMINISTRATION OF LOW-DOSE COLCHICINE AFTER MYOCARDIAL INFARCTION

#738
US20230364041A1
Human necessities

USE OF PARABULIN FOR TARGETING PROTOZOAN TUBULIN FOR THE INHIBITION OF PROTOZOAN REPLICATION

#739
US20230364042A1
Human necessities

ADMINISTRATION OF BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN HUMANS FOR THE TREATMENT AND/OR PREVENTION OF RESPIRATORY ILLNESSES

#740
US20230364043A1
Human necessities

C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION

#741
US20230364044A1
Human necessities

Methods of Treating or Preventing Acute Respiratory Distress Syndrome

#742
US20230364046A1
Human necessities

REACTIVATION OF mTOR IN ACUTE KIDNEY INJURY (AKI)

#743
US20230364047A1
Human necessities

USE OF ESTER GROUP-CONTAINING AROMATIC PROPIONAMIDE COMPOUND IN PREPARATION OF MEDICINE FOR TREATING DRY EYE SYNDROME

#744 ✅ Patent 12,138,238 granted on 2024-11-12
US20230364048A1
Human necessities

Compositions comprising N-Acetyl Methyl GABA and related methods

#745
US20230364049A1
Human necessities

COMBINATION OF P2Y6 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS

#746
US20230364050A1
Human necessities

METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOF

#747
US20230364051A1
Human necessities

FORMULATIONS AND METHODS FOR IMPROVING AVIAN HEALTH

#748
US20230364052A1
Human necessities

COMPOSITION AND METHOD FOR TREATING AUTISM

#749
US20230364053A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PROSTATE CANCER OR BREAST CANCER

#750
US20230364054A1
Human necessities

METHODS FOR TREATING COVID-19

#751 ✅ Patent 12,121,509 granted on 2024-10-22
US20230364055A1
Human necessities

Methods of improving renal function

#752
US20230364057A1
Human necessities

BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF

#753 ✅ Patent 12,064,415 granted on 2024-08-20
US20230364058A1
Human necessities

Psilocin prodrug compounds and methods of synthesizing the same

#754
US20230364059A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITION

#755
US20230364060A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

#756
US20230364061A1
Human necessities

THIAZOLIDINE DERIVATIVES FOR INHIBITING CAV3.2-USP5 INTERACTIONS

#757
US20230364062A1
Human necessities

METHOD OF TREATING MYELOID MALIGNANCIES

#758
US20230364063A1
Human necessities

ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME

#759
US20230364064A1
Human necessities

USE OF TETRANDRINE IN COMBINATION WITH ALL-TRANS RETINOIC ACID IN PREPARATION OF MEDICAMENT FOR TREATING PNEUMOCONIOSIS

#760
US20230364065A1
Human necessities

ANTIBIOTIC COMBINATION THERAPIES

#761 ✅ Patent 12,005,052 granted on 2024-06-11
US20230364066A1
Human necessities

Topical roflumilast formulation having improved delivery and plasma half-life

#762
US20230364067A1
Human necessities

ANTIFUNGAL AGENTS WITH ENHANCED ACTIVITY IN ACIDIC PH

#763
US20230364068A1
Human necessities

Nimodipine Parenteral Administration

#764
US20230364069A1
Human necessities

METHOD FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS THROUGH CO-ADMINISTRATION OF CURCUMIN DERIVATIVE AND TGF-B RECEPTOR INHIBITOR

#765
US20230364070A1
Human necessities

PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER

#766
US20230364071A1
Human necessities

Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological Chaperones

#767
US20230364072A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING RHEUMATOID ARTHRITIS

#768
US20230364073A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES

#769
US20230364074A1
Human necessities

Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting

#770
US20230364075A1
Human necessities

MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE

#771
US20230364076A1
Human necessities

USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SULPHATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS

#772 ✅ Patent 12,121,517 granted on 2024-10-22
US20230364077A1
Human necessities

Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases

#773
US20230364078A1
Human necessities

METHOD OF PREPARING NANOPARTICLES COMPRISING POORLY WATER SOLUBLE DRUGS FOR TREATING HEPATITIS

#774
US20230364079A1
Human necessities

COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

#775
US20230364080A1
Human necessities

TREATING SPONDYLOARTHRITIC AND PSORIATIC CONDITIONS WITH UPADACITINIB

#776
US20230364081A1
Human necessities

METHOD AND FORMULATION FOR TREATING MALE PREMATURE EJACULATION

#777
US20230364082A1
Human necessities

MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS

#778
US20230364083A1
Human necessities

HISTONE DEACETYLASE 6 (HDAC6) BIOMARKERS IN MULTIPLE MYELOMA

#779
US20230364084A1
Human necessities

METHODS FOR PREVENTING OR TREATING CONDITIONS RELATED TO PIKFYVE ACTIVITY

#780
US20230364085A1
Human necessities

USE OF MODULATORS OF CCR5 IN THE TREATMENT OF CANCER AND CANCER METASTASIS

#781
US20230364086A1
Human necessities

COMBINATION THERAPIES WITH EHMT2 INHIBITORS

#782
US20230364087A1
Human necessities

THERAPEUTIC TARGETING OF ACTIVATED AVIL-INDUCED SARCOMAS

#783 ✅ Patent 12,257,251 granted on 2025-03-25
US20230364088A1
Human necessities

Use of FAK inhibitor in preparation of drug for treating tumors having NRAS mutation

#784
US20230364089A1
Human necessities

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION

#785
US20230364090A1
Human necessities

FORMULATIONS/COMPOSITIONS COMPRISING A BTK INHIBITOR

#786
US20230364091A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER

#787
US20230364092A1
Human necessities

SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR

#788
US20230364093A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING PALBOCICLIB AND LETROZOLE

#789
US20230364094A1
Human necessities

DEUTERATED RUC-4

#790
US20230364095A1
Human necessities

TOPICAL TREATMENT OF VITILIGO

#791
US20230364096A1
Human necessities

USE OF A COMBINATION COMPRISING A BTK INHIBITOR FOR TREATING CANCERS

#792
US20230364097A1
Human necessities

TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS

#793
US20230364098A1
Human necessities

HSPC-SPARING TREATMENTS FOR RB-POSITIVE ABNORMAL CELLULAR PROLIFERATION

#794
US20230364099A1
Human necessities

SOLID STATE FORMS OF RESMETIROM

#795
US20230364100A1
Human necessities

METHODS OF TREATING PDE IV-MEDIATED DISEASES OR CONDITIONS

#796
US20230364101A1
Human necessities

DICLOFENAC PRODRUG AND USE OF THE SAME

#797
US20230364102A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#798
US20230364104A1
Human necessities

PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF HUMAN HYPOCHOLINERGIC DISORDERS

#799 ✅ Patent 11,890,288 granted on 2024-02-06
US20230364105A1
Human necessities

Sulfonamide or sulfinamide compound having effect of inducing BRD4 protein degradation and pharmaceutical use thereof

#800
US20230364106A1
Human necessities

PARENTERAL DOSAGE FORM OF DILTIAZEM

#801 ✅ Patent 12,059,426 granted on 2024-08-13
US20230364107A1
Human necessities

Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof

#802 ✅ Patent 12,226,421 granted on 2025-02-18
US20230364108A1
Human necessities

Nefopam dosage forms and methods of treatment

#803
US20230364109A1
Human necessities

GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUS

#804 ✅ Patent 11,938,142 granted on 2024-03-26
US20230364110A1
Human necessities

Methods and compositions for treating amyotrophic lateral sclerosis

#805
US20230364111A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS

#806
US20230364112A1
Human necessities

Use of Antcin H and Its Derivatives for Treating Central Nervous System Diseases

#807
US20230364113A1
Human necessities

PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES TO THE RECTUM

#808
US20230364114A1
Human necessities

PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF USING THEREOF

#809
US20230364115A1
Human necessities

NOVEL PSYCHEDELIC COMPOSITIONS, DELIVERY SYSTEMS AND THERAPEUTIC USES THEREOF

#810
US20230364116A1
Human necessities

PARENTERAL NUTRITION FORMULATION AND METHODS OF PREPARATION THEREOF

#811
US20230364117A1
Human necessities

BRAIN HEALTH SUPPLEMENTS

#812
US20230364118A1
Human necessities

RIBITOL TREATMENT

#813
US20230364119A1
Human necessities

AUTOPHAGY ACTIVATOR

#814
US20230364121A1
Human necessities

NIRAN INTERFERING DRUGS FOR SARS-COV-2 MUTANT THERAPY

#815
US20230364122A1
Human necessities

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

#816 ✅ Patent 12,016,875 granted on 2024-06-25
US20230364123A1
Human necessities

Methods for treating or preventing ophthalmological conditions

#817
US20230364124A1
Human necessities

METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES

#818
US20230364125A1
Human necessities

CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS

#819
US20230364127A1
Human necessities

EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6

#820
US20230364128A1
Human necessities

TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION

#821
US20230364129A1
Human necessities

TOPICAL COMPOSITIONS

#822
US20230364130A1
Human necessities

INHALED ARGON FOR TREATING A PATIENT SUFFERING FROM CARDIOVASCULAR DISEASE

#823
US20230364131A1
Human necessities

GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL ISCHEMIC STROKES

#824
US20230364132A1
Human necessities

GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL STROKES

#825
US20230364133A1
Human necessities

DIETARY SUPPLEMENT COMPOSITIONS

#826
US20230364134A1
Human necessities

METHOD FOR IMPROVING HEALTH CONDITIONS

#827
US20230364135A1
Human necessities

GUT-SELECTIVE SEQUESTERING AGENTS FOR THE TREATMENT AND PREVENTION OF AUTISM AND RELATED DISORDERS

#828
US20230364136A1
Human necessities

T lymphocyte and applications thereof

#829
US20230364137A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR EXPRESSION SYSTEMS

#830
US20230364138A1
Human necessities

ENGINEERED T CELLS FOR EXPRESSION OF CHIMERIC ANITGEN RECEPTORS

#831
US20230364139A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA

#832
US20230364140A1
Human necessities

T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF

#833 ✅ Patent 12,365,711 granted on 2025-07-22
US20230364141A1
Human necessities

TGFBETA SIGNAL CONVERTOR

#834
US20230364142A1
Human necessities

COMPOSITION FOR ANTIVIRUS COMPRISING NATURAL KILLER CELL

#835
US20230364143A1
Human necessities

PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION

#836
US20230364144A1
Human necessities

STIMULATION OF OVARIAN FUNCTION SUBSEQUENT TO CHEMOTHERAPY AND/OR RADIATION THERAPY USING NATURAL KILLER CELLS

#837
US20230364145A1
Human necessities

Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune Disease

#838
US20230364146A1
Human necessities

COMPOSITIONS AND METHODS FOR CD30 GENE MODIFICATION

#839
US20230364147A1
Human necessities

METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS

#840
US20230364148A1
Human necessities

INHIBITION AND REVERSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ENDOTHELIAL CELL REGENERATION

#841 ✅ Patent 12,303,536 granted on 2025-05-20
US20230364149A1
Human necessities

Method for treating heart failure

#842
US20230364150A1
Human necessities

METHOD FOR ISOLATION AND PURIFICATION OF MICROVESICLES FROM CELL CULTURE SUPERNATANTS AND BIOLOGICAL FLUIDS

#843
US20230364152A1
Human necessities

COMPOSITIONS AND METHODS OF USE FOR INFUSIBLE EXTRACELLULAR MATRIX

#844
US20230364153A1
Human necessities

METHOD FOR DIRECT REPROGRAMMING FROM SOMATIC CELLS INTO PANCREATIC BETA CELLS BY USING MICRORNA, AND DIFFERENTIATION COMPOSITION

#845 ✅ Patent 12,246,041 granted on 2025-03-11
US20230364154A1
Human necessities

Methods and articles of manufacture for animal therapeutics

#846
US20230364155A1
Human necessities

FETAL SUPPORT TISSUE PRODUCTS AND METHODS OF USE

#847
US20230364156A1
Human necessities

TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS

#848
US20230364157A1
Human necessities

KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA

#849
US20230364158A1
Human necessities

METHODS AND MATERIALS FOR TREATING GASTROINTESTINAL DISORDERS

#850
US20230364159A1
Human necessities

MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE

#851
US20230364160A1
Human necessities

METHOD FOR TREATING PARKINSON’S DISEASE BY USING PARABACTEROIDES GOLDSTEINII

#852 ✅ Patent 12,329,785 granted on 2025-06-17
US20230364161A1
Human necessities

METHODS AND COMPOSITIONS OF BIOCONTROL OF PLANT PATHOGENS

#853
US20230364162A1
Human necessities

METHODS AND COMPOSITIONS FOR INTESTINAL INFLAMMATION

#854
US20230364163A1
Human necessities

ENHANCEMENT OF ANTITUMOR EFFECT OF IMMUNE CHECKPOINT INHIBITOR THROUGH ADMINISTRATION OF INTESTINAL RUMINOCOCCACEAE BACTERIUM

#855
US20230364164A1
Human necessities

FECAL MATTER FOR PREVENTING OR TREATING INTESTINAL MICROBIOME ABERRATIONS IN CESAREAN SECTION-BORN INFANTS

#856
US20230364165A1
Human necessities

METHODS AND COMPOSITIONS TO MODULATE ANTIBIOTIC RESISTANCE AND GASTROINTESTINAL MICROBIOTA

#857
US20230364166A1
Human necessities

APPLICATION OF POSTBIOTICS OF INACTIVATED LACTOBACILLUS CASEI IOB-P9 IN BLOOD GLUCOSE REDUCING

#858
US20230364167A1
Human necessities

ONCOLYTIC VACCINIA VIRUS DEFICIENT IN LARGE REGION OF GENES

#859
US20230364168A1
Human necessities

COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE

#860 ✅ Patent 12,138,287 granted on 2024-11-12
US20230364169A1
Human necessities

Use of Antrodia cinnamomea for increasing alcohol metabolism or/and hangover

#861
US20230364170A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING OBESITY OR DIABETES, COMPRISING ACANTHOPANAX SENTICOSUS EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM

#862
US20230364171A1
Human necessities

SENSORY MODIFIER COMPOUNDS

#863
US20230364172A1
Human necessities

MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY

#864
US20230364173A1
Human necessities

SYNERGISTIC HERBAL COMPOSITIONS FOR IMMUNITY, COLD AND COUGH

#865
US20230364174A1
Human necessities

METHOD FOR PRODUCING EXTRACT COMPOSITION

#866
US20230364175A1
Human necessities

HERBAL COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME

#867
US20230364176A1
Human necessities

ANTI-INFLAMMATORY FORMULATION-COATED TRANSDERMAL PATCH

#868
US20230364177A1
Human necessities

PROCESS FOR ENHANCING ORGANOLEPTIC PROPERTIES OF NATURAL PRODUCTS AND NATRACEUTICALS THEREOF

#869
US20230364178A1
Human necessities

Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells

#870 ✅ Patent 12,168,034 granted on 2024-12-17
US20230364179A1
Human necessities

Inhibition of TREM receptor signaling with peptide variants

#871
US20230364180A1
Human necessities

COMPOSITION FOR IMPROVING MILD COGNITIVE IMPAIRMENT AND METHOD FOR IMPROVING MILD COGNITIVE IMPAIRMENT

#872
US20230364181A1
Human necessities

TREATMENT OF HMGB1-MEDIATED INFLAMMATION

#873 ✅ Patent 12,178,843 granted on 2024-12-31
US20230364182A1
Human necessities

Cyclosporine formulations for use in the treatment of bronchiolitis obliterans syndrome (BOS)

#874
US20230364183A1
Human necessities

CARTILAGE-HOMING PEPTIDES

#875
US20230364184A1
Human necessities

RESPIRATORY VIRUS THERAPEUTIC COMPOSITIONS AND METHODS OF PREPARATION AND USE

#876 ✅ Patent 12,318,428 granted on 2025-06-03
US20230364185A1
Human necessities

VEGFR fusion protein pharmaceutical composition

#877 ✅ Patent 12,329,803 granted on 2025-06-17
US20230364186A1
Human necessities

METHOD OF TREATING OR AMELIORATING A PATHOGENIC INFECTION BY ADMINISTERING AN INTERLEUKIN-2/TGF-BETA RECEPTOR FUSION POLYPEPTIDE

#878
US20230364187A1
Human necessities

COMPOSITION INCLUDING PLGF FOR PREVENTION OR TREATMENT OF NEUROPSYCHOLOGIC DISEASE

#879
US20230364188A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR OTIC ADMINISTRATION

#880
US20230364189A1
Human necessities

Method to Improve Neurologic Outcomes in Temperature Managed Patients

#881
US20230364190A1
Human necessities

USE OF BMP9 IN COMBINATION WITH NK CELL AND PD-L1 ANTIBODY IN PREPARING MEDICAMENT FOR TREATING LIVER CANCER

#882
US20230364191A1
Human necessities

COMPOSITIONS AND METHODS FOR PERSONALIZED TREATMENT OF NEURODEGENERATIVE CONDITIONS OR SIDE EFFECTS THEREOF

#883
US20230364192A1
Human necessities

MODULATION OF BETA CELL REGENERATION THROUGH GPR75 SIGNALING

#884
US20230364193A1
Human necessities

COMBINED DRUG FOR TREATING CORONARIVUS DISEASE 2019

#885
US20230364194A1
Human necessities

GLP-1R/GCGR Dual Target Agonist Polypeptide Derivative for Treatment of Hepatic Fibrosis Associated with Viral Hepatitis

#886
US20230364196A1
Human necessities

METHODS FOR TREATING GRAFT-VERSUS-HOST DISEASE USING GLP-2 AGONISTS AND ANALOGUES THEREOF

#887
US20230364198A1
Human necessities

C-Peptide as a Therapy for Patients with Diabetes

#888
US20230364199A1
Human necessities

IMPROVEMENT OF PHYSICAL AND MENTAL WELL-BEING OF PATIENTS WITH HYPOPARATHYROIDISM

#889
US20230364200A1
Human necessities

GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS

#890
US20230364201A1
Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING INSULIN-LIKE GROWTH FACTOR-2 AND USE THEREOF

#891
US20230364202A1
Human necessities

MICROPARTICLE-BASED ENZYME SYSTEMS FOR SELECTIVE REMOVAL OF TARGET MOLECULES

#892
US20230364203A1
Human necessities

New Granules for Animal Feed

#893
US20230364204A1
Human necessities

Bioactive Peptides, Compositions, Production Process, and Use of Bioactive Peptides as Anti-Tumoral Agents

#894
US20230364205A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER

#895
US20230364206A1
Human necessities

GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE

#896
US20230364207A1
Human necessities

MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE

#897
US20230364208A1
Human necessities

EFFECTIVE DOSAGE OF RECOMBINANT SERPIN-FC FUSION PROTEIN FOR USE IN A METHOD OF TREATING AAT DEFICIENCY IN A SUBJECT

#898
US20230364209A1
Human necessities

IMMUNOGENIC SCHISTOSOMA COMPOSITIONS

#899
US20230364210A1
Human necessities

ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE

#900
US20230364211A1
Human necessities

NUCLEOTIDE SEQUENCE EXPRESSING AN EXOSOME-ANCHORING PROTEIN FOR USE AS VACCINE